ICD-10

ICD-10 code G13.2

You are here: Home > ICD-10-CM > G00-G99 > G10-G14 > G13

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- G00-G99
Diseases of the nervous system
- G10-G14
Systemic atrophies primarily affecting the central nervous system
- G13
Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

G13.2

Systemic atrophy primarily affecting the central nervous system in myxedema

ICD-10 code G13.2 for Systemic atrophy primarily affecting the central nervous system in myxedema

Code first underlying disease, such as:
hypothyroidism (E03.-)
myxedematous congenital iodine deficiency (E00.1)
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us